ArifMK,ArifM,AmjadN., 2016.A histopathological outlook on nephrotic syndrome: A pediatric perspective,Indian J Nephrol 26 188 -
Kuzma-MroczkowskaE,SkrzypczykP,Panczyk-TomaszewskaM., 2016.Levamisole therapy in children with frequently relapsing and steroid-dependent nephrotic syndrome: a single-center experience,Cent Eur J Immunolo 41 243 -
GbadegesinRA,WinnMP,SmoyerWE, 2013.Genetic testing in nephrotic syndrome - challenges and opportunities,Nat Rev Nephrol 9 179 -84
ZaguryA,de OliveiraAL,de Araujo MontalvãoJA,NovaesRH,de SáVM, 2011.Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndrome,Pediatr Nephrol 26 915 -20
VesterU,KranzB,ZimmermannS,HoyerPF, 2003.Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook,Pediatr Nephrol 18 661 -4
WebbNJ,FrewE,BrettellEA,MilfordDV,BockenhauerD,SaleemMA, 2014.Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial,Trials 15 147 -
HodsonEM,WillisNS,CraigJC, 2007.Corticosteroid therapy for nephrotic syndrome in children,Cochrane Database Syst Rev 4 CD001533 -
HahnD,HodsonEM,WillisNS,CraigJC, 2015.Corticosteroid therapy for nephrotic syndrome in children,Cochrane Libr 18 -
HodsonEM,KnightJF,WillisNS,CraigJC, 2000.Corticosteroid therapy for nephrotic syndrome in children,Cochrane Database Syst Rev 4 CD001533 -
HodsonEM,KnightJF,WillisNS,CraigJC, ., -
HodsonEM,KnightJF,WillisNS,CraigJC, 2003.Corticosteroid therapy for nephrotic syndrome in children,Cochrane Database Syst Rev 1 CD001533 -
HodsonEM,KnightJF,WillisNS,CraigJC, 2005.Corticosteroid therapy for nephrotic syndrome in children,Cochrane Database Syst Rev 1 CD001533 -
UedaN,KunoK,ItoS. Eight, 1990.and 12-week courses of cyclophosphamide in nephrotic syndrome,Arch Dis Child 65 1147 -50
RadhakrishnanJ,CattranDC, 2012.The KDIGO practice guideline on glomerulonephritis: reading between the (guide) linesapplication to the individual patient,Kidney Int 82 840 -56
OemarBS,BrodehlJ, 1987.Cyclophosphamide treatment of steroid dependent nephrotic syndrome - comparison of 8-week with 12-week course,Arch Dis Child 62 1102 -6
GarinEH,PryorND,FennellRS,RichardGA, 1978.Pattern of response to prednisone in idiopathic, minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy,J Pediatr 92 304 -8
TakedaA,OhgushiH,NiimuraF, 1998.Matsutani H. Long-term effects of immunosuppressants in steroid-dependent nephrotic syndrome,Pediatr Nephrol 12 746 -50
KyrieleisHA,LevtchenkoEN,WetzelsJF, 2007.Long-term outcome after cyclophosphamide treatment in children with steroiddependent and frequently relapsing minimal change nephrotic syndrome,Am J Kidney Dis 49 592 -7
WebbH,JaureguiberryG,DufekS,TullusK,BockenhauerD, 2016.Cyclophosphamide and rituximab in frequently relapsing/ steroid-dependent nephrotic syndrome,Pediatr Nephrol 31 589 -94
van HusenM,Kemper MJ, 2011.New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome,Pediatr Nephrol 26 881 -92
AzibS,MacherMA,KwonT,DechartresA,AlbertiC,LoiratC, 2011.Cyclophosphamide in steroid-dependent nephrotic syndrome,Pediatr Nephrol 26 927 -32
LanewalaA,MubarakM,KaziJI,AkhterF,SherA,FayyazA, 2012.A clinicopathologic study of primary focal segmental glomerulosclerosis in children,Saudi J Kidney Dis Transplant 23 513 -
MartinelliR,PereiraLJ,SilvaOM,OkumuraAS,RochaH., 2004.Cyclophosphamide in the treatment of focal segmental glomerulosclerosis,Braz J Med Biol Res 37 1365 -72